DiaSorin stock trades at EUR 77.45 with P/ E 24.1

Published on 10/09/2026 at 17:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DiaSorin stock costs EUR 77.45 on October 9, 2026 after EUR 75.86, plus 2.10 percent. Its P/E ratio is 24.1.

Key points in brief

DiaSorin stock stood at EUR 77.45 at Lang & Schwarz on October 9, 2026 at 5:41 p.m. CEST, plus 2.10 percent versus EUR 75.86.
The price was 2.85 percent below the 52-week high of EUR 79.72 and above the 52-week low of EUR 52.34.
Market capitalization was EUR 3.8 billion, with a P/E ratio of 24.1 and a next earnings date of November 5, 2026.

Techniker im Reinraum bedienen automatisierte Diagnostikgeräte in modernem Biotech-Labor — Modernes Diagnostiklabor von DiaSorin S.p.A., ISIN IT0003497168, zeigt präzise Biotech-Produktion und klinische Fertigung, Illustration mit AI erstellt.

DiaSorin (ISIN IT0003492391) stood at EUR 77.45 at Lang & Schwarz on October 9, 2026 at 5:41 p.m. CEST, up 2.10 percent from the prior close of EUR 75.86. The move leaves the diagnostics group close to its annual high while the valuation remains a central market measure.

Price stays near yearly high

The spread at Lang & Schwarz was EUR 0.06, with a bid of EUR 77.42 and an ask of EUR 77.48 on October 9, 2026. The price was EUR 2.27 below the 52-week high of EUR 79.72 and EUR 25.11 above the low of EUR 52.34.

That placement puts the stock 2.85 percent below its 52-week high, calculated from the same euro quotation and range. The reference point matters because the current level is only EUR 2.27 from the upper end of the annual band.

Valuation carries the market report

DiaSorin had a market capitalization of EUR 3.8 billion and a P/E ratio of 24.1 on October 9, 2026. The finance data also showed a dividend yield of 0.02 percent, keeping the valuation profile centered on earnings rather than income.

DiaSorin reported EUR 1.2 billion of revenue, EUR 394.0 million of adjusted EBITDA and EUR 223.0 million of adjusted net profit in fiscal year 2025. Free cash flow for the same period was EUR 209.0 million, giving the market capitalization a reported operating reference.

Comparison with peers

DiaSorin: plus 2.10 percent, P/E 24.1, market capitalization EUR 3.8 billion
Qiagen (Nasdaq, USD): plus 1.28 percent, P/E 23.1, market capitalization USD 9.3 billion
FTSE MIB (Italy, EUR): daily change not stated, P/E not stated, market capitalization not stated

Next results date is November 5

The next earnings date listed for DiaSorin is November 5, 2026, according to InvestPane. That date gives the valuation figures a defined event horizon, while the annual price range supplies the immediate trading context.

Euro price after the Xetra close

DiaSorin stood at EUR 77.45 at Lang & Schwarz on October 9, 2026 at 5:41 p.m. CEST, plus 2.10 percent versus the EUR 75.86 prior close. The quote was captured after the Xetra close, while the stock remained within its EUR 52.34 to EUR 79.72 52-week range.

The further course of trading is shown by the continuously updated real-time quote of DiaSorin stock.